TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
New addition expands reconstruction options for surgeons and patientsMALVERN, Pa., Aug. 16, 2023 -- TELA Bio, Inc. , a commercial-stage medical technology company focused on providing innovative... -Today at 07:02 am- MarketScreener
Source: marketscreener.com